CPT code 78315 – Three-phase bone scan

Key takeaways

CPT 78315 describes bone and/or joint imaging as a three-phase study. Vascular flow, blood pool, and delayed static images must all be performed and documented.

Technique defines 78315, so the area imaged never decides it. The code cannot be billed on the same day as 78306 or 78300.

HCPCS A9503, the Tc-99m medronate tracer, is billed separately from 78315 and never bundled into the procedure code.

A report that omits the injection and acquisition times gets downcoded to 78300 or 78305 on audit.

Pabau’s claims management software supports CPT code entry, ICD-10 linkage, modifier assignment, and separate line-item billing for radiopharmaceuticals.

CPT code 78315: Definition and quick-reference data

CPT code 78315 is the American Medical Association code for “Bone and/or joint imaging; 3 phase study.” It covers one targeted area imaged across a vascular flow phase, a blood pool phase, and a delayed static phase.

All three acquisitions happen in a single encounter. The code is reportable by the interpreting physician, the facility, or both, depending on who provides which component.

What does the three-phase bone scan procedure cover?

The three-phase bone scan requires three sequential imaging acquisitions in a single encounter, each capturing different physiological information about the target site.

All three phases must be performed and individually documented for 78315 to be correctly reported. Skipping a phase, or omitting its documentation, is the most common reason a correctly performed scan gets downcoded to 78300 or 78305 on audit.

1. Vascular flow phase (dynamic phase): Dynamic images are acquired immediately after intravenous injection of Tc-99m MDP. They capture perfusion of the target area over the first 60 seconds. This phase assesses blood flow and identifies hyperemia associated with infection, RSD/CRPS, or acute fracture.
2. Blood pool phase (soft tissue phase): Static images acquired approximately 5 to 10 minutes post-injection reflect the distribution of tracer in blood and soft tissues. Increased uptake at this phase, combined with flow phase findings, supports an inflammatory or infectious process.
3. Delayed static phase (bone phase): Skeletal images are obtained 2 to 4 hours after injection. By then the tracer has cleared the soft tissues and concentrated where osteoblastic activity is increased. This is the definitive bone-uptake phase and the one most readers think of when they picture a bone scan.

Each phase has its own clock, and each clock has to appear in the report. The sequence below sets out the three acquisition windows alongside the time point every one of them must record.

The nuclear medicine report must confirm all three phases were acquired. It must also state the time intervals between injection and each acquisition, and carry the interpreting physician’s attestation.

A report that documents only the delayed phase is technically a single-phase study, which supports 78300 or 78305. That pattern is common in busier departments.

78315 vs 78306 vs 78300: Choosing the right code

Two variables separate the four bone-scan codes in the 78000 series: the number of phases performed, and the area of the body imaged.

CPT code 78315 turns entirely on its three-phase technique, and it covers a targeted area rather than the whole skeleton. That matters because 78315 and 78306 are mutually exclusive on the same date of service. Billing both constitutes unbundling.

A practical way to hold the distinction is to listen to the ordering clinician’s question. If it is “is there infection, vascular compromise, or complex regional pain?”, the answer needs all three phases, and that is 78315. If it is “where are the metastases?”, a whole-body delayed scan under 78306 is the right report.

Clinical indications and ICD-10 linkage

Every 78315 claim requires a supporting ICD-10-CM diagnosis code that demonstrates medical necessity. MAC Local Coverage Determinations specify which diagnoses are accepted for nuclear medicine bone imaging.

The table below reflects commonly covered indications, and full descriptors for each entry sit in the ICD-10-CM code library. Covered codes vary by region, so verify against the MAC LCD for your own jurisdiction.

Radiopharmaceutical billing: HCPCS code A9503

The radiopharmaceutical used in a three-phase bone scan is technetium-99m medronate, also written as Tc-99m MDP. It is billed separately under HCPCS Level II code A9503, and never bundled into CPT code 78315.

Facilities that leave A9503 off the claim collect less than the study earned. Facilities that fold it into the procedure line expose themselves on audit.

• Who bills A9503: Typically the nuclear medicine facility or hospital outpatient department that prepares and administers the dose. Freestanding nuclear pharmacies may bill separately, depending on payer contract. Confirm with each payer before assuming the facility claim captures the dose.
• Dose units: A9503 is billed per millicurie (mCi). A standard adult three-phase bone scan dose is typically 20-30 mCi. Document the administered dose in millicuries in the nuclear medicine report, because payers increasingly audit this.
• Payer variation: Some commercial payers bundle A9503 into the facility fee, and others reimburse it as a separate line item. Medicare Part B reimburses A9503 as a separate HCPCS code under the Physician Fee Schedule when a physician or freestanding facility bills it. Hospital outpatients fall under OPPS APC packaging rules instead. Verify current payer policy before assuming global reimbursement.
• Common error: Billing A9503 twice, once on the facility claim and once on the professional claim. The result is an overpayment demand. A9503 belongs on the claim of the entity that supplied the dose.

Modifiers that apply to 78315

Modifier selection for CPT code 78315 depends on who performs and interprets the study, and where the service is provided. Applying the wrong modifier is a consistent trigger for claim rejection. So is omitting one when billing in a split-service setting. The table below sets out the four combinations that cover almost every 78315 claim.

Modifier 52 (reduced services) is sometimes appended when fewer than three phases are completed because the patient could not tolerate the study. Billing 78315-52 in that scenario is incorrect. The right code is 78300 or 78305, chosen on the phases that were performed. Consult the relevant MAC LCD and coding policy before reaching for Modifier 52.

Medicare reimbursement and fee schedule for 78315

Medicare reimbursement for CPT code 78315 is set under the CMS Physician Fee Schedule (MPFS). For hospital outpatients it is set under the Outpatient Prospective Payment System (OPPS).

The figures below are national averages for 2026, and payment varies by locality through the Geographic Practice Cost Index (GPCI). Verify the current figure before billing, using the CMS MPFS lookup tool or an RVU calculator such as FastRVU.

Private payer rates typically exceed Medicare by 10 to 40 percent, depending on payer and geography. Some commercial contracts reimburse A9503 at cost plus a markup, which makes an accurate dose record worth the minute it takes to write.

Checking eligibility before the study confirms that the patient’s plan covers nuclear medicine imaging at the rate the practice is expecting.

Documentation requirements for a compliant 78315 claim

The nuclear medicine report is the single document auditors check when a 78315 claim is questioned. Missing one required element is enough to trigger a downcode. Every imaging report submitted with a 78315 claim should carry all five elements below.

1. Confirmation all three phases were performed: The report must state that a three-phase study was conducted, rather than reference a “bone scan.” Phase-specific headings (Flow Phase, Blood Pool Phase, Delayed Imaging) strengthen the audit trail.
2. Radiopharmaceutical name, dose, and route: Document “Tc-99m MDP, [X] mCi, IV” with the administered dose. This is required for A9503 billing and for MAC LCD compliance.
3. Time points for each phase: Record the clock time of injection. Then record the time of blood pool imaging (typically T+5 to T+10 minutes) and of delayed imaging (typically T+2h to T+4h). Absent time points are an audit flag.
4. Interpreting physician attestation: Signed attestation from the nuclear medicine physician or radiologist who reviewed the images and generated the report. Unsigned or auto-populated reports without physician review fail most MAC audits.
5. ICD-10 clinical indication: The report must state the clinical question being answered, such as “rule out osteomyelitis left foot”. It must also link to the ordering ICD-10 code. A report that describes findings without naming the clinical question gives the payer nothing to test medical necessity against.

Omitting the time points for the blood pool or flow phase converts a 78315 into a 78300 more often than any other documentation error. Coders should request an amended report before submitting whenever one of the five elements above is missing.

Common claim denials and how to avoid them

CPT code 78315 denies in a predictable pattern, which makes it a good candidate for front-end claim edits. Each row below names the root cause and the check that catches it before the claim is submitted. Build those checks into the billing workflow and most of this table stops applying to your practice.

Billing CPT 78315 in practice management software

Entering CPT code 78315 correctly in a practice management system takes more configuration than a standard E/M code. Two claim lines and one modifier have to be set up: 78315 itself, the A9503 radiopharmaceutical line, and the modifier matching the service split. Practices that treat 78315 as a single-line entry under-collect and carry avoidable audit risk.

• Code entry: Select 78315 with the correct modifier (26, TC, or global) matching the place of service and service split. Never default to global without confirming the entity bills both components.
• ICD-10 linkage: Attach the primary ICD-10 diagnosis code documented in the ordering physician’s notes and referenced in the nuclear medicine report. The system should flag claims with no linked diagnosis before submission.
• A9503 as a separate line item: Add A9503 as a distinct line on the same claim, carrying the administered dose in millicuries. The line belongs to the entity that supplied the dose. It should never be embedded in the 78315 line or treated as a procedure modifier.
• Prior authorization field: Record the PA number in the claim’s authorization field for any payer that requires pre-certification. Missing this field on a payer that requires it is an automatic denial.

Practice management software like Pabau holds all three elements on one screen. Pabau’s claims management software links the ICD-10 diagnosis to the procedure and keeps the modifier tied to the place of service. A9503 sits on its own line. The billing team sees the claim in the shape the payer expects, before it goes out.

Validation against payer edits then catches a missing modifier or an unlinked diagnosis while the claim can still be corrected. On a code like 78315 the money sits across two lines. That check decides whether the claim clears on first pass or comes back for rework.

Reduce claim denials on complex nuclear medicine codes

Pabau helps billing teams attach the right modifier and link the ICD-10 diagnosis. A9503 stays on its own line, and every check runs before the claim reaches the payer.

Book a demo

Conclusion

Two errors cost more on 78315 than all the others put together. One is the downcode that follows a report with no phase times in it. The other is the A9503 line nobody added. Both come from treating a three-phase study as a single-line entry.

The fix sits upstream of the claim, not in the appeal. Agree a report template with the nuclear medicine department that prints the injection time and both acquisition times. Then make the A9503 line mandatory on the claim form. Once both are in place, 78315 stops being a code that needs watching.

Book a demo to see how Pabau keeps the modifier, the diagnosis link, and the radiopharmaceutical line together on a single claim.

Continue your research

Need to understand how clearinghouse claims validation works? Clean claim submission covers the front-end checks that prevent nuclear medicine claims from failing on first pass.

Billing A9503 alongside a procedure code for the first time? Superbill construction explains how to structure multi-line claims including radiopharmaceuticals correctly.

Navigating insurance eligibility before a scan? Insurance eligibility verification walks through how to confirm nuclear medicine coverage before the patient arrives.

Frequently asked questions